Andrew Norstrud, the Chief Financial Officer of UPEXI, INC, purchased 43,860 shares of common stock on April 17, 2025, at a price of $2.28 per share. Additionally, he received 100,000 shares under the company's Restricted Stock Award Agreement, which will vest over the next 10 months commencing April 17, 2025. Such stock purchases usually indicate that the company's stock price is undervalued, which can be regarded as a bullish signal. Investors should take note.